[Federal Register Volume 62, Number 198 (Tuesday, October 14, 1997)]
[Notices]
[Page 53334]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-27095]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meetings

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Heart, Lung, and Blood Institute Special Emphasis Panel (SEP) 
meetings:

    Name of SEP: Transfusion-Associated Immunomodulation (TRIM) 
Telephone Conference Call.
    Date: November 5, 1997.
    Time: 1:30 p.m.
    Place: Two Rockledge Center, Room 7214, 6701 Rockledge Drive, 
Bethesda, Maryland 20892.
    Contact Person: Louise Corman, Ph.D., Two Rockledge Center, Room 
7180, 6701 Rockledge Drive, Bethesda, MD 20892-7924, (301) 435-0270.
    Purpose/Agenda: To review and evaluate contract proposals.

    Name of SEP: Lipoprotein Metabolism in Atherosclerosis.
    Date: December 8-9, 1997.
    Time: 7:30 p.m.
    Place: Holiday Inn Chevy Chase, 5520 Wisconsin Avenue, Chevy 
Chase, Maryland 20815.
    Contact Person: Ivan Baines, Ph.D., Two Rockledge Center, Room 
7184, 6701 Rockledge Drive, Bethesda, MD 20892-7924, (301) 435-0277.
    Purpose/Agenda: To review and evaluate grant applications.
    These meetings will be closed in accordance with the provisions 
set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C. 
Applications and/or contract proposals and the discussions could 
reveal confidential trade secrets or commercial property such as 
patentable material and personal information concerning individuals 
associated with the applications and/or proposals, the disclosure of 
which would constitute a clearly unwarranted invasion of personal 
privacy.

(Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart 
and Vascular Diseases Research; 93.838, Lung Diseases Research; and 
93.839, Blood Diseases and Resources Research, National Institutes 
of Health)

    Dated: October 6, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-27095 Filed 10-10-97; 8:45 am]
BILLING CODE 4140-01-M